Chil Covid-19 Saliva Antigen Test
The CHIL COVID-19 Antigen Rapid Test is used to detect proteins (antigens) from the SARS-CoV-2 virus using a saliva sample.
The CHIL COVID-19 Antigen Rapid Test is an in vitro diagnostic device that is used for the qualitative detection of nucleocapsid protein antigens of SARS-CoV-2 in human saliva
Limit of Detection study is conducted to test CHIL COVID-19 Antigen Rapid Test performance for to set LoD level. LoD studies determine the lowest detectable concentration of SARS-CoV-2 at which
approximately 95% of all (true positive) replicates test positive.
This cross-reaction study is performed to verify the influence of common respiratory pathogens on the detection performance of CHIL® COVID-19 Antigen Rapid Test.
CHIL Covid-19 Antigen Rapid Test is designed to capture SARS-CoV-2 nucleocapsid protein. Therefore device’s claim is a pre-diagnostic approach to Covid-19. The result of the product should not be taken as a confirmed diagnosis, but for clinical reference only.
No microbial interference effect was observed for all the tested SARS CoV-2 positive samples with the mixed microorganisms on the CHILD COVID-19 Antigen Rapid Test results.
Interference testing was performed to evaluate CHILD COVID-19 Antigen Rapid Test performance with common substances.
The study is intended to test the CHILD COVID-19 Antigen Rapid Test for the high concentration of SARS-CoV-2 for the Hook effect.
The Test is a rapid, qualitative immunochromatographic assay for the determination of the presence of SARS-CoV-2 antigens indirect human saliva. The test strip is composed of the following parts: sample pad, reagent pad, reaction membrane, and absorbing pad.
The CHIL COVID-19 Antigen Rapid Test is used to detect proteins (antigens) from the SARS-CoV-2 virus using a saliva sample.
The CHIL COVID-19 Antigen Rapid Test is an in vitro diagnostic device that is used for the qualitative detection of nucleocapsid protein antigens of SARS-CoV-2 in human saliva
Limit of Detection study is conducted to test CHIL COVID-19 Antigen Rapid Test performance for to set LoD level. LoD studies determine the lowest detectable concentration of SARS-CoV-2 at which
approximately 95% of all (true positive) replicates test positive.
This cross-reaction study is performed to verify the influence of common respiratory pathogens on the detection performance of CHIL® COVID-19 Antigen Rapid Test.
CHIL Covid-19 Antigen Rapid Test is designed to capture SARS-CoV-2 nucleocapsid protein. Therefore device’s claim is a pre-diagnostic approach to Covid-19. The result of the product should not be taken as a confirmed diagnosis, but for clinical reference only.
No microbial interference effect was observed for all the tested SARS CoV-2 positive samples with the mixed microorganisms on the CHILD COVID-19 Antigen Rapid Test results.
Interference testing was performed to evaluate CHILD COVID-19 Antigen Rapid Test performance with common substances.
The study is intended to test the CHILD COVID-19 Antigen Rapid Test for the high concentration of SARS-CoV-2 for the Hook effect.
The Test is a rapid, qualitative immunochromatographic assay for the determination of the presence of SARS-CoV-2 antigens indirect human saliva. The test strip is composed of the following parts: sample pad, reagent pad, reaction membrane, and absorbing pad.
The CHIL COVID-19 Antigen Rapid Test is used to detect proteins (antigens) from the SARS-CoV-2 virus using a saliva sample.
The CHIL COVID-19 Antigen Rapid Test is an in vitro diagnostic device that is used for the qualitative detection of nucleocapsid protein antigens of SARS-CoV-2 in human saliva
Limit of Detection study is conducted to test CHIL COVID-19 Antigen Rapid Test performance for to set LoD level. LoD studies determine the lowest detectable concentration of SARS-CoV-2 at which
approximately 95% of all (true positive) replicates test positive.
This cross-reaction study is performed to verify the influence of common respiratory pathogens on the detection performance of CHIL® COVID-19 Antigen Rapid Test.
CHIL Covid-19 Antigen Rapid Test is designed to capture SARS-CoV-2 nucleocapsid protein. Therefore device’s claim is a pre-diagnostic approach to Covid-19. The result of the product should not be taken as a confirmed diagnosis, but for clinical reference only.
No microbial interference effect was observed for all the tested SARS CoV-2 positive samples with the mixed microorganisms on the CHILD COVID-19 Antigen Rapid Test results.
Interference testing was performed to evaluate CHILD COVID-19 Antigen Rapid Test performance with common substances.
The study is intended to test the CHILD COVID-19 Antigen Rapid Test for the high concentration of SARS-CoV-2 for the Hook effect.
The Test is a rapid, qualitative immunochromatographic assay for the determination of the presence of SARS-CoV-2 antigens indirect human saliva. The test strip is composed of the following parts: sample pad, reagent pad, reaction membrane, and absorbing pad.